New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
07:36 EDTBCR, MDTMedtronic balloon likely to be superior to C.R. Bard product, says Wells Fargo
After examining data disclosed by C.R. Bard (BCR) on its drug-coated balloon, Wells Fargo thinks the efficacy of Medtronic's drug-coated balloon will be superior. The firm keeps an Outperform rating on Medtronic.
News For MDT;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2015
06:59 EDTMDTMedtronic volatility flat into Q2 and outlook
Subscribe for More Information
November 24, 2015
08:31 EDTMDTMedtronic remains a top tier performer in Med Device space, says Cowen
Subscribe for More Information
November 23, 2015
08:36 EDTBCRC.R. Bard acquisition positive, says JMP Securities
After C.R. Bard agreed to buy Liberator Medical, JMP Securities says the deal "will bring incremental reimbursement expertise, potentially open the door to other chronic disease states, increase direct contact with patients and... provide a tailwind of about 2% to sales and some EPS accretion." The firm reiterates a $207 price target and Outperform rating on C.R. Bard.
November 20, 2015
07:28 EDTBCRLiberator Medical to be acquired by C.R. Bard for $3.35 per share
Subscribe for More Information
07:28 EDTBCRC.R. Bard to acquire Liberator Medical for roughly $181M
C.R. Bard (BCR) announced that it has entered into a definitive agreement to acquire Liberator Medical Holdings (LBMH) for $3.35 per share, or approximately $181M. This transaction is structured as a merger, has been approved by each company's board of directors, and is subject to customary closing conditions, including approval of the shareholders of Liberator and regulatory approvals. The company expects the transaction to close in the first quarter of 2016 and add approximately $70M to 2016 net sales and to be slightly accretive to adjusted cash earnings per share in 2016. The company estimates that in 2017 this acquisition will increase the organic revenue growth rate of the company and contribute between 5c-10c of adjusted cash earnings per share.
05:22 EDTMDTStocks with implied volatility movement; MDT UNH
Stocks with implied volatility movement; Medtronic (MDT) 25, UnitedHealth (UNH) 30 according to iVolatility.
November 17, 2015
16:45 EDTBCRCryoLife resolves PerClot litigation with Medafor
Subscribe for More Information
16:44 EDTBCRCryoLife and C.R. Bard subsidiary enter into patent resolution
Subscribe for More Information
09:14 EDTMDTMedtronic announces FDA approval, launch of MyCareLink Smart Monitor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use